XML 62 R36.htm IDEA: XBRL DOCUMENT v3.6.0.2
Organization, Basis of Presentation and Liquidity, General (Details)
12 Months Ended
Dec. 31, 2016
Technology
Program
Sector
Subsidiary
Feb. 17, 2017
May 13, 2016
Dec. 31, 2015
Dec. 31, 2014
Organization, Basis of Presentation and Liquidity [Abstract]          
Number of platform technologies | Technology 2        
Number of clinical stage programs | Program 3        
Number of primary sectors | Sector 3        
Number of subsidiaries | Subsidiary 2        
Asterias Biotherapeutics, Inc. [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method ownership percentage 48.70%   57.10%    
Equity method ownership percentage after public offering     48.70%    
Asterias Biotherapeutics, Inc. [Member] | Maximum [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method ownership percentage 50.00%        
OncoCyte Corporation [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method ownership percentage       57.80% 76.50%
OncoCyte Corporation [Member] | Maximum [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method ownership percentage 50.00%        
OncoCyte Corporation [Member] | Subsequent Event [Member] | Maximum [Member]          
Schedule of Equity Method Investments [Line Items]          
Equity method ownership percentage   50.00%